Craneware, a leading healthcare software provider based in the U.K., announced that its pretax profit for fiscal year 2023 saw a marginal decline. However, this decrease was offset by higher revenue, resulting in a balanced financial performance for the company.
Financial Overview
For the year ending June 30, pretax profit stood at $13.085 million, a slight decrease compared to the $13.102 million recorded in the previous year. Despite this, Craneware experienced a 5% increase in revenue, reaching $174.0 million. Furthermore, adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), excluding exceptional and one-off items, demonstrated a positive growth of 6% from the previous year, amounting to $54.9 million.
Dividend Increase
In view of the company’s overall performance, Craneware’s board proposed an augmented final dividend of 20.19 U.S. cents per share for fiscal year 2023. This marks an improvement from the 18.80 cents declared in the previous fiscal year. Consequently, the total dividend for the year rose to 35.95 cents per share, up from 33.96 cents.
Positive Outlook for the Future
Craneware’s CEO, Keith Neilson, expressed satisfaction with the company’s sales momentum at the end of the fiscal year, which has carried forward into the new financial year. This strong sales pipeline sets a promising foundation for future success. The company is confident in its prospects for fiscal year 2024 and beyond, thanks to a robust balance sheet, substantial annual recurring revenue, and early indications of growing customer confidence.
For more information: Craneware
